Cargando…
Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden
BACKGROUND: Immunotherapy has provided an effective method for the treatment of many cancers. However, its efficacy in osteosarcoma is not satisfactory so far. CASE PRESENTATION: Here, we presented a case of osteosarcoma treated with sequential chemotherapy and immunotherapy and showed promising the...
Autores principales: | Zheng, Shuier, Wang, Fenglin, Huang, Jin, Zhou, Yan, Yang, Quanjun, Qian, Guowei, Zhou, Chenliang, Min, Daliu, Song, Lele, Shen, Zan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249865/ https://www.ncbi.nlm.nih.gov/pubmed/34220700 http://dx.doi.org/10.3389/fendo.2021.625226 |
Ejemplares similares
-
N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1
por: Zhou, Chenliang, et al.
Publicado: (2020) -
The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021) -
The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data
por: Li, Hongtao, et al.
Publicado: (2013) -
Fibrinogen–Albumin Ratio Index Exhibits Predictive Value of Neoadjuvant Chemotherapy in Osteosarcoma
por: Li, Zhendong, et al.
Publicado: (2022) -
TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1
por: Zheng, Shuier, et al.
Publicado: (2020)